Advances in screening technologies have enabled the
identification of interactive gene combinations, enabling the development of
lead candidates that leverage the principle of synthetic lethality for cancer
treatment
To order this 485+ page report, which features 195+ figures
and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html
The USD 8 billion (by 2030) financial opportunity within
the synthetic lethality-based drugs and targets market has been analyzed across
the following segments:
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
- Rest
of the World
The “Synthetic
Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair
(including PARP Inhibitors) and Other Novel Cellular Pathways”.report features the following companies, which
we identified to be key players in this domain:
§
§
§
§
§
§
§
§
§
§
§
§
§
Table of Contents
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
